Stock XLO XILIO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Xilio Therapeutics, Inc.

Equities

XLO

US98422T1007

Delayed Nasdaq
Other stock markets
 09:43:46 2024-05-09 am EDT 		5-day change 1st Jan Change
1.16 USD -4.13% Intraday chart for Xilio Therapeutics, Inc. +10.48% +110.91%
Apr. 19 Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says MT
Apr. 01 Xilio Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. XLO Stock
  4. Revisions Xilio Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW